These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17473072)

  • 1. Rosiglitazone prevents free fatty acid-induced vascular endothelial dysfunction.
    Mittermayer F; Schaller G; Pleiner J; Krzyzanowska K; Kapiotis S; Roden M; Wolzt M
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2574-80. PubMed ID: 17473072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the renin-angiotensin system prevents free fatty acid-induced acute endothelial dysfunction in humans.
    Watanabe S; Tagawa T; Yamakawa K; Shimabukuro M; Ueda S
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2376-80. PubMed ID: 16179595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiponectin concentrations increase during acute FFA elevation in humans treated with rosiglitazone.
    Krzyzanowska K; Mittermayer F; Krugluger W; Roden M; Schernthaner G; Wolzt M
    Horm Metab Res; 2007 Oct; 39(10):769-72. PubMed ID: 17952842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free fatty acids normalize a rosiglitazone-induced visfatin release.
    Haider DG; Mittermayer F; Schaller G; Artwohl M; Baumgartner-Parzer SM; Prager G; Roden M; Wolzt M
    Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E885-90. PubMed ID: 16735449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone.
    Tack CJ; Ong MK; Lutterman JA; Smits P
    Diabetologia; 1998 May; 41(5):569-76. PubMed ID: 9628275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma free fatty acids and endothelium-dependent vasodilation: effect of chain-length and cyclooxygenase inhibition.
    de Kreutzenberg SV; Crepaldi C; Marchetto S; Calò L; Tiengo A; Del Prato S; Avogaro A
    J Clin Endocrinol Metab; 2000 Feb; 85(2):793-8. PubMed ID: 10690892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of rosiglitazone on insulin resistance, C-reactive protein and endothelial function in non-obese young women with polycystic ovary syndrome.
    Tarkun I; Cetinarslan B; Türemen E; Sahin T; Cantürk Z; Komsuoglu B
    Eur J Endocrinol; 2005 Jul; 153(1):115-21. PubMed ID: 15994753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FFA-induced endothelial dysfunction can be corrected by vitamin C.
    Pleiner J; Schaller G; Mittermayer F; Bayerle-Eder M; Roden M; Wolzt M
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2913-7. PubMed ID: 12050273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone causes endothelial dysfunction in humans.
    Perampaladas K; Gori T; Parker JD
    J Cardiovasc Pharmacol Ther; 2012 Sep; 17(3):260-5. PubMed ID: 22053074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free fatty acid-induced insulin resistance in the obese is not prevented by rosiglitazone treatment.
    Dhindsa S; Tripathy D; Sanalkumar N; Ravishankar S; Ghanim H; Aljada A; Dandona P
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5058-63. PubMed ID: 15985490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of improvement in endothelium-dependent flow-mediated vasodilation after rosiglitazone to changes in asymmetric dimethylarginine, endothelin-1, and C-reactive protein in nondiabetic patients with the metabolic syndrome.
    Wang TD; Chen WJ; Cheng WC; Lin JW; Chen MF; Lee YT
    Am J Cardiol; 2006 Oct; 98(8):1057-62. PubMed ID: 17027571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free fatty acids do not acutely increase asymmetrical dimethylarginine concentrations.
    Namiranian K; Mittermayer F; Artwohl M; Pleiner J; Schaller G; Mayer BX; Bayerle-Eder M; Roden M; Baumgartner-Parzer S; Wolzt M
    Horm Metab Res; 2005 Dec; 37(12):768-72. PubMed ID: 16372232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation.
    Steinberg HO; Tarshoby M; Monestel R; Hook G; Cronin J; Johnson A; Bayazeed B; Baron AD
    J Clin Invest; 1997 Sep; 100(5):1230-9. PubMed ID: 9276741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term triglyceride lowering with fenofibrate improves vasodilator function in subjects with hypertriglyceridemia.
    Capell WH; DeSouza CA; Poirier P; Bell ML; Stauffer BL; Weil KM; Hernandez TL; Eckel RH
    Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):307-13. PubMed ID: 12588776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of rosiglitazone on endothelial function in men with coronary artery disease without diabetes mellitus.
    Sidhu JS; Cowan D; Kaski JC
    Am J Cardiol; 2004 Jul; 94(2):151-6. PubMed ID: 15246889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-arterial vitamin C prevents endothelial dysfunction caused by ischemia-reperfusion.
    Pleiner J; Schaller G; Mittermayer F; Marsik C; MacAllister RJ; Kapiotis S; Ziegler S; Ferlitsch A; Wolzt M
    Atherosclerosis; 2008 Mar; 197(1):383-91. PubMed ID: 17645881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid effects of rosiglitazone treatment on endothelial function and inflammatory biomarkers.
    Hetzel J; Balletshofer B; Rittig K; Walcher D; Kratzer W; Hombach V; Häring HU; Koenig W; Marx N
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1804-9. PubMed ID: 16002742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Insulin mitigates the effect of free fatty acid to cause endothelial dysfunction in rat aortic rings].
    Yu Y; Zhu J; Wu Y; Baron AD
    Zhonghua Yi Xue Za Zhi; 2002 Mar; 82(6):422-5. PubMed ID: 11953213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pioglitazone on insulin sensitivity, vascular function and cardiovascular inflammatory markers in insulin-resistant non-diabetic Asian Indians.
    Raji A; Gerhard-Herman MD; Williams JS; O'connor ME; Simonson DC
    Diabet Med; 2006 May; 23(5):537-43. PubMed ID: 16681563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARγ activation does not affect endothelin activity in non-diabetic patients with hypertension or hypercholesterolemia.
    Campia U; Matuskey LA; Tesauro M; Cardillo C; Panza JA
    Atherosclerosis; 2014 Jun; 234(2):436-40. PubMed ID: 24769306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.